{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T11:28:10Z","timestamp":1765279690621},"reference-count":51,"publisher":"Tohoku University Medical Press","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tohoku J. Exp. Med."],"published-print":{"date-parts":[[2009]]},"DOI":"10.1620\/tjem.218.293","type":"journal-article","created":{"date-parts":[[2009,7,29]],"date-time":"2009-07-29T05:59:24Z","timestamp":1248847164000},"page":"293-300","source":"Crossref","is-referenced-by-count":11,"title":["Hyperhomocysteinemia as an Independent Risk Factor for Cardioembolic Stroke in the Turkish Population"],"prefix":"10.1620","volume":"218","author":[{"given":"Nida","family":"Tascilar","sequence":"first","affiliation":[{"name":"Department of Neurology, Zonguldak Karaelmas University Medical Faculty"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sureyya","family":"Ekem","sequence":"additional","affiliation":[{"name":"Department of Neurology, Zonguldak Karaelmas University Medical Faculty"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esra","family":"Aciman","sequence":"additional","affiliation":[{"name":"Department of Neurology, Zonguldak Karaelmas University Medical Faculty"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Handan","family":"Ankarali","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Zonguldak Karaelmas University Medical Faculty"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gorkem","family":"Mungan","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Zonguldak Karaelmas University Medical Faculty"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Banu","family":"Ozen","sequence":"additional","affiliation":[{"name":"Department of Neurology, Zonguldak Karaelmas University Medical Faculty"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aysun","family":"Unal","sequence":"additional","affiliation":[{"name":"Department of Neurology, Zonguldak Karaelmas University Medical Faculty"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"622","reference":[{"key":"1","unstructured":"Adams, H.P., Bendixen, B.H., Kappelle, L.J., Biller, J., Love, B.B., Gordon, D.L. &amp; Marsh, E.E. 3rd. (1993) Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. <i>Stroke<\/i>, <b>24<\/b>, 35-41."},{"key":"2","doi-asserted-by":"crossref","unstructured":"Akaike, M., Azuma, H., Kagawa, A., Matsumoto, K., Hayashi, I., Tamura, K., Nishiuchi, T., Iuchi, T., Takamori, N., Aihara, K., Yoshida, T., Kanagawa, Y. &amp; Matsumoto, T. (2002) Effect of aspirin treatment on serum concentrations of lipoprotein(a) in patients with atherosclerotic diseases. <i>Clin. Chem<\/i>., <b>48<\/b>, 1454-1459.","DOI":"10.1093\/clinchem\/48.9.1454"},{"key":"3","doi-asserted-by":"publisher","DOI":"10.1016\/0021-9150(94)90078-7"},{"key":"4","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.0000060202.63475.BA"},{"key":"5","unstructured":"Biller, J. &amp; Love, B.B. (2004) Ischemic Cerebrovascular Disease. In <i>Neurology in Clinical Practice<\/i>, 4th ed., edited by W.G. Bradley, R.B. Daroff, G.M. Fenichel &amp; J. Jankovic. Butterworth Heinemann, Philadelphia, PA, pp. 1197-1249."},{"key":"6","doi-asserted-by":"crossref","unstructured":"Bots, M.L., Launer, L.J., Lindemans, J., Hoes, A.W., Hofman, A., Witteman, J.C.M., Koudstaal, P.J. &amp; Grobbee, D.E. (1999) Homocysteine and short-term risk of myocardial infarction and stroke in the elderly: the Rotterdam study. <i>Arch. Intern. Med<\/i>., <b>159<\/b>, 38-44.","DOI":"10.1001\/archinte.159.1.38"},{"key":"7","doi-asserted-by":"crossref","unstructured":"Censori, B., Partziguian, T., Manara, O. &amp; Poloni, M. (2007) Plasma homocysteine and severe white matter disease. <i>Neurol. Sci<\/i>., <b>28<\/b>, 259-263.","DOI":"10.1007\/s10072-007-0832-y"},{"key":"8","doi-asserted-by":"publisher","DOI":"10.1023\/A:1017286006708"},{"key":"9","doi-asserted-by":"crossref","unstructured":"Cingozbay, B.Y., Yiginer, O., Cebeci, B.S., Kardesoglu, E., Demiralp, E. &amp; Dincturk, M. (2002) Role of homocysteine for thromboembolic complication in patients with non-valvular atrial fibrillation. <i>Blood Coagul. Fibrinolysis<\/i>, <b>13<\/b>, 609-613.","DOI":"10.1097\/00001721-200210000-00005"},{"key":"10","doi-asserted-by":"crossref","unstructured":"Dhamija, R.K., Gaba, P., Arora, S., Kaintura, A., Kumar, M. &amp; Bhattacharjee, J. (2009) Homocysteine and lipoprotein (a) correlation in ischemic stroke patients. <i>J. Neurol. Sci<\/i>., <b>281<\/b>, 64-68.","DOI":"10.1016\/j.jns.2009.02.341"},{"key":"11","doi-asserted-by":"crossref","unstructured":"Eikelboom, J.W., Hankey, G.J., Anand, S.S., Lofthouse, E., Staples, N. &amp; Baker, R.I. (2000) Association between high homocysteine and ischemic stroke due to large- and small-artery disease but not other etiologic subtypes of ischemic stroke. <i>Stroke<\/i>, <b>31<\/b>, 1069-1075.","DOI":"10.1161\/01.STR.31.5.1069"},{"key":"12","doi-asserted-by":"crossref","unstructured":"Evers, S., Koch, H.G., Grotemeyer, K.H., Lange, B., Deufel, T. &amp; Ringelstein, E.B. (1997) Features, symptoms, and neurophysiological findings in stroke associated with hyperhomocysteinemia. <i>Arch. Neurol<\/i>., <b>54<\/b>, 1276-1282.","DOI":"10.1001\/archneur.1997.00550220074017"},{"key":"13","doi-asserted-by":"crossref","unstructured":"Freyburger, G., Labrouche, S., Sassoust, G., Rouanet, F., Javorschi, S. &amp; Parrot, F. (1997) Mild hyperhomocysteinemia and hemostatic factors in patients with arterial vascular diseases. <i>Thromb. Haemost<\/i>., <b>77<\/b>, 466-471.","DOI":"10.1055\/s-0038-1655990"},{"key":"14","doi-asserted-by":"crossref","unstructured":"Friedman, H.S. (2001) Serum homocysteine and stroke in atrial fibrillation. <i>Ann. Intern. Med<\/i>., <b>134<\/b>, 253-254.","DOI":"10.7326\/0003-4819-134-3-200102060-00027"},{"key":"15","doi-asserted-by":"crossref","unstructured":"Giles, W.H., Croft, J.B., Greenlund, K.J., Ford, E.S. &amp; Kittner, S.J. (1998) Total homocysteine concentration and the likelihood of nonfatal stroke: results from the Third National Health and Nutrition Examination Survey, 1988-1994. <i>Stroke<\/i>, <b>29<\/b>, 2473-2477.","DOI":"10.1161\/01.STR.29.12.2473"},{"key":"16","doi-asserted-by":"crossref","unstructured":"Glueck, C.J., Shaw, P., Lang, J.E., Tracy, T., Smith, L.S. &amp; Wang, Y. (1995) Evidence that homocysteine is an independent risk factor for atherosclerosis in hyperlipidemic patients. <i>Am. J. Cardiol<\/i>., <b>75<\/b>, 132-136.","DOI":"10.1016\/S0002-9149(00)80061-2"},{"key":"17","doi-asserted-by":"publisher","DOI":"10.1001\/jama.277.22.1775"},{"key":"18","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)11058-9"},{"key":"19","doi-asserted-by":"crossref","unstructured":"Hankey, G.J. &amp; Warlow, C.P. (1999) Treatment and secondary prevention of stroke: evidence, costs, and effects on individuals and populations. <i>Lancet<\/i>, <b>354<\/b>, 1457-1463.","DOI":"10.1016\/S0140-6736(99)04407-4"},{"key":"20","doi-asserted-by":"crossref","unstructured":"Hart, R.G., Benavente, O., McBride, R. &amp; Pearce, L.A. (1999) Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: a meta-analysis. <i>Ann. Intern. Med<\/i>., <b>131<\/b>, 492-501.","DOI":"10.7326\/0003-4819-131-7-199910050-00003"},{"key":"21","doi-asserted-by":"crossref","unstructured":"Kittner, S.J., Giles, W.H., Macko, R.F., Hebel, J.R., Wozniak, M.A., Wityk, R.J., Stolley, P.D., Stern, B.J., Sloan, M.A., Sherwin, R., Price, T.R., McCarter, R.J., Johnson, C.J., Earley C.J., Buchholz, D.W. &amp; Malinow, M.R. (1999) Homocyst(e)ine and risk of cerebral infarction in a biracial population: the stroke prevention in young women study. <i>Stroke<\/i>, <b>30<\/b>, 1554-1560.","DOI":"10.1161\/01.STR.30.8.1554"},{"key":"22","doi-asserted-by":"crossref","unstructured":"Li, Z., Sun, L., Zhang, H., Liao, Y., Wang, D., Zhao, B., Zhu, Z., Zhao, J., Ma, A., Han, Y., Wang, Y., Shi, Y., Ye, J. &amp; Hui, R.; Multicenter Case-Control Study in China. (2003) Elevated plasma homocysteine was associated with hemorrhagic and ischemic stroke, but methylenetetrahydrofolate reductase gene C677T polymorphism was a risk factor for thrombotic stroke. A multicenter case-control study in China. <i>Stroke<\/i>, <b>34<\/b>, 2085-2090.","DOI":"10.1161\/01.STR.0000086753.00555.0D"},{"key":"23","unstructured":"Loffredo, L., Violi, F., Fimognari, F.L., Cangemi, R., Sbrighi, P.S., Sampietro, F., Mazzola, G., Di Lecce, V.N. &amp; D'Angelo, A. (2005) The association between hyperhomocysteinemia and ischemic stroke in patients with non-valvular atrial fibrillation. <i>Haematologica<\/i>, <b>90<\/b>, 1205-1211."},{"key":"24","doi-asserted-by":"crossref","unstructured":"Madonna, P., de Stefano, V., Coppola, A., Cirillo, F., Cerbone, A.M., Orefice, G. &amp; Di Minno, G. (2002) Hyperhomocysteinemia and other inherited prothrombotic conditions in young adults with a history of ischemic stroke. <i>Stroke<\/i>, <b>33<\/b>, 51-56.","DOI":"10.1161\/hs0102.100483"},{"key":"25","doi-asserted-by":"publisher","DOI":"10.1097\/00041433-200308000-00004"},{"key":"26","unstructured":"McCully, K.S. (1969) Vascular pathology of homocysteinemia: implications for the pathogenesis of atherosclerosis. <i>Am. J. Pathol<\/i>., <b>56<\/b>, 111-128."},{"key":"27","doi-asserted-by":"crossref","unstructured":"McQuillan, B.M., Beilby, J.P., Nidorf, M., Thompson, P.L. &amp; Hung, J. (1999) Hyperhomocysteinemia but not the C677T mutation of methylenetetrahydrofolate reductase is an independent risk determinant of carotid wall thickening. The Perth Carotid Ultrasound Disease Assessment Study (CUDAS). <i>Circulation<\/i>, <b>99<\/b>, 2383-2388.","DOI":"10.1161\/01.CIR.99.18.2383"},{"key":"28","doi-asserted-by":"crossref","unstructured":"Naruszewicz, M., Klinke, M., Dziewanowski, K., Staniewicz, A. &amp; Bukowska, H. (2001) Homocysteine, fibrinogen, and lipoprotein(a) levels are simultaneously reduced in patients with chronic renal failure treated with folic acid, pyridoxine, and cyanocobalamin. <i>Metabolism<\/i>, <b>50<\/b>, 131-134.","DOI":"10.1053\/meta.2001.20174"},{"key":"29","doi-asserted-by":"crossref","unstructured":"Ntaios, G.C., Savopoulos, C.G., Chatzinikolaou, A.C., Kaiafa, G.D. &amp; Hatzitolios, A. (2008) Vitamins and stroke: the homocysteine hypothesis still in doubt. <i>Neurologist<\/i>, <b>14<\/b>, 2-4.","DOI":"10.1097\/01.nrl.0000253066.85963.aa"},{"key":"30","doi-asserted-by":"crossref","unstructured":"Nygard, O., Refsum, H., Ueland, P.M. &amp; Vollset, S.E. (1998) Major lifestyle determinants of plasma total homocysteine distribution: the Hordaland Homocysteine Study. <i>Am. J. Clin. Nutr<\/i>., <b>67<\/b>, 263-270.","DOI":"10.1093\/ajcn\/67.2.263"},{"key":"31","doi-asserted-by":"crossref","unstructured":"O'Callaghan, P., Meleady, R., Fitzgerald, T. &amp; Graham, I.; the European COMAC group. (2002) Smoking and plasma homocysteine. <i>Eur. Heart. J<\/i>., <b>23<\/b>, 1580-1586.","DOI":"10.1053\/euhj.2002.3172"},{"key":"32","doi-asserted-by":"crossref","unstructured":"Okubadejo, N.U., Oladipo, O.O., Adeyomoye, A.A., Awosanya, G.O. &amp; Danesi, M.A. (2008) Exploratory study of total homocysteine and its relationship to short-term outcome in acute ischaemic stroke in Nigerians. <i>BMC Neurol<\/i>., <b>8<\/b>, 26.","DOI":"10.1186\/1471-2377-8-26"},{"key":"33","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(95)92407-8"},{"key":"34","doi-asserted-by":"crossref","unstructured":"Pezzini, A., Grassi, M., Del Zotto, E., Assanelli, D., Archetti, S., Negrini, R., Caimi, L. &amp; Padovani, A. (2006) Interaction of homocysteine and conventional predisposing factors on risk of ischaemic stroke in young people: consistency in phenotype-disease analysis and genotype-disease analysis. <i>J. Neurol. Neurosurg. Psychiatry<\/i>, <b>77<\/b>, 1150-1156.","DOI":"10.1136\/jnnp.2005.076083"},{"key":"35","doi-asserted-by":"crossref","unstructured":"Piyathilake, C.J., Macaluso, M., Hine, R.J., Richards, E.W. &amp; Krumdieck, C.L. (1994) Local and systemic effects of cigarette smoking on folate and vitamin B-12. <i>Am. J. Clin. Nutr<\/i>., <b>60<\/b>, 559-566.","DOI":"10.1093\/ajcn\/60.4.559"},{"key":"36","doi-asserted-by":"crossref","unstructured":"Poli, D., Antonucci, E., Cecchi, E., Marcucci, R., Liotta, A.A., Cellai, A.P., Lenti, M., Gensini, G.F., Abbate, R. &amp; Prisco, D. (2005) Culprit factors for the failure of well-conducted warfarin therapy to prevent ischemic events in patients with atrial fibrillation: the role of homocysteine. <i>Stroke<\/i>, <b>36<\/b>, 2159-2163.","DOI":"10.1161\/01.STR.0000183620.06179.7b"},{"key":"37","doi-asserted-by":"crossref","unstructured":"Pulkkinen, A., Viitanen, L., Kareinen, A., Lehto, S. &amp; Laakso, M. (2000) MspI polymorphism at +83 bp in intron 1 of the human apolipoprotein A1 gene is associated with elevated levels of HDL cholesterol and apolipoprotein A1 in nondiabetic subjects but not in type 2 diabetic patients with coronary heart disease. <i>Diabetes Care<\/i>, <b>23<\/b>, 791-795.","DOI":"10.2337\/diacare.23.6.791"},{"key":"38","doi-asserted-by":"crossref","unstructured":"Refsum, H., Nurk, E., Smith, A.D., Ueland, P.M., Gjesdal, C.G., Bjelland, I., Tverdal, A., Tell, G.S., Nyg&aring;rd, O. &amp; Vollset, S.E. (2006) The Hordaland Homocysteine Study: a community-based study of homocysteine, its determinants, and association with disease. <i>J. Nutr<\/i>., <b>136<\/b>, 1731S-1740S.","DOI":"10.1093\/jn\/136.6.1731S"},{"key":"39","doi-asserted-by":"crossref","unstructured":"Refsum, H., Smith, A.D., Ueland, P.M., Nexo, E., Clarke, R., McPartlin, J., Johnston, C., Engbaek, F., Schneede, J., McPartlin, C. &amp; Scott, J.M. (2004) Facts and recommendations about total homocysteine determinations: an expert opinion. <i>Clin. Chem<\/i>., <b>50<\/b>, 3-32.","DOI":"10.1373\/clinchem.2003.021634"},{"key":"40","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.med.49.1.31"},{"key":"41","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.0000142374.33919.92"},{"key":"42","doi-asserted-by":"publisher","DOI":"10.1159\/000047739"},{"key":"43","unstructured":"Spence, J.D. (2006) Nutrition and stroke prevention. <i>Stroke<\/i>, <b>37<\/b>, 2430-2435."},{"key":"44","doi-asserted-by":"crossref","unstructured":"Spence, J.D., Malinow, M.R., Barnett, P.A., Marian, A.J., Freeman, D. &amp; Hegele, R.A. (1999) Plasma homocysteine concentration, but not MTHFR genotype, is associated with variation in carotid plaque area. <i>Stroke<\/i>, <b>30<\/b>, 969-973.","DOI":"10.1161\/01.STR.30.5.969"},{"key":"45","doi-asserted-by":"crossref","unstructured":"Ueland, P.M., Refsum, H., Beresford, S.A.A. &amp; Vollset, S.E. (2000) The controversy over homocysteine and cardiovascular risk. <i>Am. J. Clin. Nutr<\/i>., <b>72<\/b>, 324-332.","DOI":"10.1093\/ajcn\/72.2.324"},{"key":"46","doi-asserted-by":"crossref","unstructured":"Verhoef, P., Hennekens, C.H., Malinow, M.R., Kok, F.J., Willett, W.C. &amp; Stampfer, M.J. (1994) A prospective study of plasma homocysteine and risk of ischemic stroke. <i>Stroke<\/i>, <b>25<\/b>, 1924-1930.","DOI":"10.1161\/01.STR.25.10.1924"},{"key":"47","doi-asserted-by":"crossref","unstructured":"Virtanen, J.K., Voutilainen, S., Alfthan, G., Korhonen, M.J., Rissanen, T.H., Mursu, J., Kaplan, G.A. &amp; Salonen, J.T. (2005) Homocysteine as a risk factor for CVD mortality in men with other CVD risk factors: the Kuopio Ischaemic Heart Disease Risk Factor (KIHD) Study. <i>J. Intern. Med<\/i>., <b>257<\/b>, 255-262.","DOI":"10.1111\/j.1365-2796.2005.01450.x"},{"key":"48","doi-asserted-by":"crossref","unstructured":"Yokote, H., Shiraishi, A., Shintani, S. &amp; Shiigai, T. (2007) Acute multiple brain infarction in large-artery atherosclerosis is associated with hyperhomocysteinemia. <i>Acta Neurol. Scand<\/i>., <b>116<\/b>, 243-247.","DOI":"10.1111\/j.1600-0404.2007.00873.x"},{"key":"49","doi-asserted-by":"crossref","unstructured":"Yoo, J.H., Chung, C.S. &amp; Kang, S.S. (1998) Relation of plasma homocysteine to cerebral infarction and cerebral atherosclerosis. <i>Stroke<\/i>, <b>29<\/b>, 2478-2483.","DOI":"10.1161\/01.STR.29.12.2478"},{"key":"50","doi-asserted-by":"crossref","unstructured":"Youssef, M.Y., Mojiminiyi, O.A. &amp; Abdella, N.A. (2007) Plasma concentrations of C-reactive protein and total homocysteine in relation to the severity and risk factors for cerebrovascular disease. <i>Transl. Res<\/i>., <b>150<\/b>, 158-163.","DOI":"10.1016\/j.trsl.2007.02.006"},{"key":"51","doi-asserted-by":"crossref","unstructured":"Zhang, G. &amp; Dai, C. (2001) Gene polymorphisms of homocysteine metabolism-related enzymes in Chinese patients with occlusive coronary artery or cerebral vascular diseases. <i>Thromb. Res<\/i>., <b>104<\/b>, 187-195.","DOI":"10.1016\/S0049-3848(01)00352-8"}],"container-title":["The Tohoku Journal of Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.jstage.jst.go.jp\/article\/tjem\/218\/4\/218_4_293\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,28]],"date-time":"2021-04-28T19:30:40Z","timestamp":1619638240000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jstage.jst.go.jp\/article\/tjem\/218\/4\/218_4_293\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009]]},"references-count":51,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1620\/tjem.218.293","relation":{},"ISSN":["0040-8727","1349-3329"],"issn-type":[{"value":"0040-8727","type":"print"},{"value":"1349-3329","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009]]}}}